SCHEMBL25826256

SCHEMBL25826256

Cc1ccc2nccc(Nc3ccc(C(=O)O)cn3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 9/20 0.50
HTR1A P08908 2/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
MAPKAPK2 P49137 2/20 0.48
HPGD P15428 1/20 0.46
LMNA P02545 2/20 0.44
KDM4E B2RXH2 2/20 0.44
POLB P06746 1/20 0.44
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
CDK1 P06493 1/20 0.44
CDK2 P24941 1/20 0.44
FLT4 P35916 1/20 0.44
FLT3 P36888 1/20 0.44
FRK P42685 1/20 0.44
CDK8 P49336 1/20 0.44
CSNK2A1 P68400 1/20 0.44
CDK5 Q00535 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999793 0.88 HCAR3 (0.50) HCAR3MAPKAPK2KDM4ERETKMT2A
SCHEMBL23999501 0.86 HCAR3 (0.48) HCAR3MAPKAPK2KDM4EHTTRET
SCHEMBL23999540 0.85 HCAR3 (0.47) HCAR3MAPKAPK2KDM4ERETMAPT
SCHEMBL23999974 0.82 GAK (0.48) HCAR3MAPKAPK2CDK8CLK4SLC22A12
SCHEMBL25826240 0.81 KMT2A (0.57) HCAR3MAPKAPK2LMNAKDM4EPOLB
SCHEMBL23999854 0.80 IP6K1 (0.43) HCAR3MAPKAPK2HPGDKDM4ECDK8
SCHEMBL23999537 0.80 MAPKAPK2 (0.43) HCAR3MAPKAPK2HPGDCDK8ACVR1
SCHEMBL23999930 0.79 KMT2A (0.51) MAPKAPK2HPGDLMNAKDM4EPOLB
SCHEMBL23999939 0.79 IP6K1 (0.45) HCAR3MAPKAPK2HPGDCDK8ACVR1
SCHEMBL23999979 0.78 MAPKAPK2 (0.42) HCAR3MAPKAPK2RETSLC22A12HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR HCAR3 596/4885HTR1A 3416/4885ADRA1D 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.